Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

15 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/15/3205285/33525/en/Roxadustat-Granted-Orphan-Drug-Designation-for-the-Treatment-of-Myelodysplastic-Syndromes-by-the-U-S-Food-and-Drug-Administration.html

10 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/10/3185020/33525/en/FibroGen-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

03 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/03/3179766/33525/en/FibroGen-to-Report-Third-Quarter-2025-Financial-Results.html

24 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/24/3155319/33525/en/FibroGen-Initiates-Phase-2-Monotherapy-Trial-of-FG-3246-a-First-in-Class-CD46-Targeting-ADC-in-Metastatic-Castration-Resistant-Prostate-Cancer.html

11 Sep 2025
// FIERCE PHARMA
https://www.fiercepharma.com//www.fiercebiotech.com/biotech/fibrogen-pays-sec-12m-over-allegations-former-exec-reverse-engineered-roxadustat-data

02 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/02/3142499/33525/en/FibroGen-Completes-Sale-of-FibroGen-China-to-AstraZeneca-for-Approximately-220-Million.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE